Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Mar 06, 2020 2:31pm
95 Views
Post# 30776706

RE:RE:My gift to Newcamo, realstocky & marcjohnson

RE:RE:My gift to Newcamo, realstocky & marcjohnson

Charm7 

I do believe that there was a ton of shorting going on and TV's dark web friends probably participated in some way. But, they may have simply capitalized on Laurin and Pritchard's (and apparently the board) mix of arrogance and ignorance. Who could not see that Ryplazim was 100% clinical functional and safe and realize that the only tricky thing to FDA approval was CMC? So, why no consultant hired back in 2015? On 4050, it definitely produced strong results in 4 different indications but not once did they add a few million to make it a placebo trial. Why would they not do a single placebo trial? Boehringer deal - too greedy as 2 other small companies got back ended investments within a year of PLI failing to come to terms. Nothing wrong with the science - it's all in the execution. Seems better so far but it's slower than slow as usual and why is the Alstrom trial design taking so long? I don't think they short this again unless it's in next few months without an announcement but if a partnership for Ryplazim and BLA amendment with priority review goes before June, sentiment may change. It's a real risky one but could pay handsomely for that risk. 


charm7 wrote:
TV made close to 1 billion shorting PLI, it seems they are trying the rope a dope by renaming Ryplazim as a new product, expect to see multi millions on the buy side when they reintroduce the product. This will suck in new investors then the Blackmomba will be back. I wish I listened to the old investors to keep my money and stay away from investing into this scam.

 

<< Previous
Bullboard Posts
Next >>